ScanTech AI Systems Inc. 8-K
Research Summary
AI-generated summary
ScanTech AI Systems Inc. Faces Nasdaq Delisting; Trading Suspended Feb 10, 2026
What Happened
ScanTech AI Systems Inc. announced that Nasdaq’s Hearing Panel denied its request to continue listing on The Nasdaq Global Market, and trading in the company’s common stock will be suspended at the open of trading on February 10, 2026. The company received a Nasdaq deficiency notice on February 4, 2026 for failing to meet the market value of publicly held shares (MVPHS) requirement and a Delisting Letter on February 6, 2026 reflecting the Panel’s January 22, 2026 hearing decision. ScanTech says it is exploring an appeal to the Nasdaq Listing and Hearing Review Council and intends to apply for quotation on the OTCQB Venture Market.
Key Details
- Nasdaq found ScanTech out of compliance with MVPHS rule after a 30-business-day review ending February 3, 2026; MVPHS must be at least $15.0 million to meet the rule.
- To cure the MVPHS deficiency, Nasdaq rules require a MVPHS of $15.0 million or more for at least 10 consecutive business days; a prior deficiency letter gave the company until August 3, 2026 (180 days) to regain compliance.
- The Nasdaq Panel determined the company violated Listing Rules 5250(c)(1) (periodic filing) and 5450(b)(2)(A) (market value/listing standard); the company has 15 days to request review by the Nasdaq Listing and Hearing Review Council.
- ScanTech plans to seek quotation on the OTCQB Venture Market but noted there is no assurance it will qualify or be approved.
Why It Matters
A Nasdaq delisting and trading suspension can materially reduce liquidity and investor access to a stock and may affect market price, volatility and the company’s ability to raise capital. The company’s immediate options are to seek a Listing Council review (which can affirm, reverse, modify or remand the Panel decision) or pursue trading on the OTCQB, which typically has lower visibility and liquidity than Nasdaq. Investors should note the Feb 10, 2026 suspension date, monitor any appeal filings and the company’s OTCQB application, and be aware the company disclosed forward-looking risks related to these outcomes.